- $856.01m
- $809.91m
- $162.02m
- 55
- 16
- 60
- 39
Annual income statement for Blend Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 96 | 234 | 235 | 157 | 162 |
| Cost of Revenue | |||||
| Gross Profit | 61.7 | 116 | 89.7 | 81.1 | 90.5 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 171 | 432 | 981 | 313 | 209 |
| Operating Profit | -75.3 | -197 | -746 | -156 | -46.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -74.6 | -208 | -766 | -180 | -43.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -74.6 | -169 | -764 | -180 | -43.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -74.6 | -170 | -769 | -185 | -60.5 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -74.6 | -171 | -769 | -185 | -60.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.34 | -0.755 | -1.99 | -0.69 | -0.227 |
| Dividends per Share |